{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:06:07Z","timestamp":1787972767269,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jdcr.2019.12.015","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T23:53:28Z","timestamp":1582070008000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series"],"prefix":"10.1016","volume":"6","author":[{"given":"Aisleen","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gillihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Motaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2019.12.015_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/ijd.14189","article-title":"A global\u00a0consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis","volume":"58","author":"Kumarasinghe","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/1346-8138.13002","article-title":"Clinical and histological aspect of erythema dyschromicum perstans in Korea: a review of 68 cases","volume":"42","author":"Chang","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/lsm.22567","article-title":"Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment","volume":"49","author":"Wolfshohl","year":"2017","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jdcr.2019.12.015_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijwd.2018.08.003","article-title":"Erythema dyschromicum perstans: a case report and systematic review of histologic presentation and treatment","volume":"4","author":"Leung","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jdcr.2019.06.014","article-title":"Proton pump inhibitor-induced erythema dyschromicum perstans-like pigmentation","volume":"5","author":"Gutierrez","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2019.12.015_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5070\/D39218V6BN","article-title":"Erythema dyschromicum perstans","volume":"16","author":"Tlougan","year":"2010","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jdcr.2019.12.015_bib7","first-page":"77","article-title":"Coexistence of erythema dyschromicum perstans and vitiligo: a case report and review of the literature","volume":"25","author":"Tamer","year":"2016","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.jdcr.2019.12.015_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ajd.12813","article-title":"A retrospective clinico-pathological study comparing lichen planus pigmentosus with ashy dermatosis","volume":"59","author":"Cheng","year":"2018","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jamadermatol.2015.6185","article-title":"Erythema dyschromicum perstans response to isotretinoin","volume":"152","author":"Wang","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib10","first-page":"25","article-title":"Erythema dyschromicum perstans: a case report and review","volume":"68","author":"Osswald","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jdcr.2019.12.015_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1365-4632.2006.02893.x","article-title":"Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis)","volume":"45","author":"Vasquez-Ochoa","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/ijd.13293","article-title":"Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study","volume":"55","author":"Muthu","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ajd.12813","article-title":"A retrospective clinico-pathological study comparing lichen planus pigmentosus with ashy dermatosis","volume":"59","author":"Cheng","year":"2018","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijwd.2018.08.003","article-title":"Erythema dyschromicum perstans: a case report and systematic review of histologic presentation and treatment","volume":"4","author":"Leung","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/abd1806-4841.20176133","article-title":"Ashy dermatosis with involvement of mucous membranes","volume":"92","author":"Rato","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/lsm.22567","article-title":"Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment","volume":"49","author":"Wolfshohl","year":"2017","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jdcr.2019.12.015_bib17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jamadermatol.2015.6185","article-title":"Erythema dyschromicum perstans response to isotretinoin","volume":"152","author":"Wang","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/1346-8138.13002","article-title":"Clinical and histological aspect of erythema dyschromicum perstans in Korea: a review of 68 cases","volume":"42","author":"Chang","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/0019-5154.164452","article-title":"Erythema dyschromicum perstans: response to topical tacrolimus","volume":"60","author":"Mahajan","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib20","first-page":"63","article-title":"Efficacy of narrowband UVB phototherapy in erythema dyschromicum perstans treatment: case reports","volume":"23","author":"Fabbrocini","year":"2015","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jdcr.2019.12.015_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jdcr.2015.04.011","article-title":"Erythema dyschromicum perstans showing resolution in an adult","volume":"1","author":"Antonov","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2019.12.015_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/09546634.2011.565016","article-title":"Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study","volume":"23","author":"Kroon","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jdcr.2019.12.015_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1524-4725.2011.02230.x","article-title":"Formation of fibrosis after nonablative and ablative fractional laser therapy","volume":"38","author":"Wind","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jdcr.2019.12.015_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000323663","article-title":"Two\u00a0cases\u00a0of unilateral ashy dermatosis","volume":"3","author":"Imanishi","year":"2011","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5070\/D39218V6BN","article-title":"Erythema dyschromicum perstans","volume":"16","author":"Tlougan","year":"2010","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jdcr.2019.12.015_bib26","first-page":"299","article-title":"Erythema dyschromicum perstans: successful treatment with clofazimine under a single-patient investigational new drug study","volume":"22","author":"Micciantuono","year":"2009","journal-title":"Cosmet Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-4632.2004.01984.x","article-title":"Erythema dyschromicum perstans: response to dapsone therapy","volume":"43","author":"Bahadir","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2019.12.015_bib28","first-page":"25","article-title":"Erythema dyschromicum perstans: a case report and review","volume":"68","author":"Osswald","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jdcr.2019.12.015_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-4362.2001.01196-2.x","article-title":"Erythema dyschromicum perstans and hepatitis C virus infection","volume":"40","author":"Kontochristopoulos","year":"2001","journal-title":"Int J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619307507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619307507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:20:44Z","timestamp":1762474844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512619307507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2352512619307507"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.12.015","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}